2023-507547-11-00招募中1 期
A randomized, double-blind, placebo-controlled, single and multiple-dose-escalation, phase 1 study in healthy volunteers and patients with ulcerative colitis to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GRT-001 (MONOlith trial)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 94
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CT information desk
Scientific
Granite Bio AG
研究点 (1)
Loading locations...
相似试验
未知
Unknown
A single intravenous dose study of E3112 in Japanese healthy adult male subjectsHealthy Adult SubjectsJPRN-jRCT2080223364EA Pharma Co.,Ltd.40
已完成
Unknown
A human study to evaluate the effect of CKDB-317 on promoting immunity functioKCT0008686Chong Kun Dang Bio100
进行中（未招募）
1 期
The pain reduction effects of different doses and modes of administration of Lopain (MTX-071) relative to placebo are evaluated in patients with chronic osteoarthritic knee joint pain.EUCTR2018-000818-37-SKGrünenthal GmbH156
尚未招募
不适用
Biperiden challenge studyNL-OMON26607Centre for Human Drug Research12
招募中
不适用
A randomized, double-blind, placebo-controlled, single dose, 3-way cross-over study in healthy elderly subjects to develop an anti-cholinergic pharmacological challenge with biperiden.Alzheimer's diseaseNL-OMON46604Centre for Human Drug Research12